(888) 31-NDASA info@NDASA.com
  • Facebook
  • X
  • Instagram
  • RSS
  • Facebook
  • X
  • Instagram
  • RSS
  • NDASA
  • NDASA University
  • Member Login
0 Items
NDASA
  • About
    • Leadership
  • Training
    • NDASA University
      • My Courses
    • NDASA University Partner Program
    • Webinars
      • Webinar Library
    • Accreditation
    • Mentorship
  • Get involved
    • Committees
      • International Council
      • Community Outreach
    • Become a Trainer
    • State Affiliate Caucus
    • Our Federal PAC
    • Board of Directors
  • Join us
    • Member Benefits
    • Sponsorships & Advertising
    • Accreditation
    • Preferred Provider
  • News
    • Resources
  • Events
    • 2026 Conference and Trade Show
    • 2025 Conference Highlights
    • Regional Training
  • Shop
  • Support
    • Sponsorships & Advertising
    • NDASA Foundation
  • Help
Select Page
NDASA’s public comments on the proposed rescheduling of marijuana – Part 2

NDASA’s public comments on the proposed rescheduling of marijuana – Part 2

by NDASA | Jul 17, 2024 | Drug Legislation, Feature, Marijuana & CBD

The Honorable Merrick B. Garland Attorney GeneralU.S. Department of Justice The Honorable Anne Milgram, Administrator Drug Enforcement Administration8701 Morrissette DriveSpringfield, Virginia 22152 Submitted via Electronic DocketJuly 17 , 2024 Re: Part 2 of 2 of the...
Marijuana legalization, the DEA and harmful, unintended consequences

Marijuana legalization, the DEA and harmful, unintended consequences

by Guest Contributer | Jul 15, 2024 | Advocacy, Drug Legislation, Feature, Marijuana & CBD, Workplace Safety

By Bill Current, Founder of the Current Consulting Group It’s been said that elections have consequences, including unintended consequences that can be harmful, nonetheless. The Drug Enforcement Administration (DEA), at President Biden’s direction, intends to...
DOT Safety Alarm: Potential changes to marijuana restrictions may result in unintended serious safety concerns for the U.S. traveling public.

DOT Safety Alarm: Potential changes to marijuana restrictions may result in unintended serious safety concerns for the U.S. traveling public.

by Guest Contributer | May 3, 2024 | Drug Legislation, Feature, Industry News, Uncategorized

Courtesy of American Substance Abuse Professionals AP News reports that the US Drug Enforcement Administration will move to reclassify  marijuana as a less dangerous drug. Reclassifying marijuana as a less dangerous drug creates medical and...
Laws protecting off-duty use of marijuana don’t mean you have to stop testing for it!

Laws protecting off-duty use of marijuana don’t mean you have to stop testing for it!

by NDASA | Jan 23, 2024 | Marijuana & CBD, Substance Use

By Buzzkill Labs Although state lawmakers approved Assembly Bill 2188 more than a year ago, there is still a lack of clarity about what it means for employers in California. Even some drug testing service providers are under the impression that AB 2188 spells the end...

Meet The Institute for Behavior and Health

by NDASA | Apr 23, 2021 | For Drug Testing Industry Professionals, For Employers and Workplace Safety & Wellness Professionals, Marijuana & CBD, Resources

The Institute for Behavior and Health, Inc., is a nonprofit organization based in Rockville, Md., that develops strategies to reduce drug use. President Robert L. DuPont, M.D., was the lead author on an extensive 2015 report titled, “Workplace Drug Testing in the Era...

U.S. DOT Recreational Marijuana Notice

by NDASA | Apr 23, 2021 | For Drug Testing Industry Professionals, Marijuana & CBD, Resources

“We want to make it perfectly clear that the state initiatives will have no bearing on the Department of Transportation’s regulated drug testing program.  The Department of Transportation’s Drug and Alcohol Testing Regulation – 49 CFR Part 40 – does not authorize the...

Video: ‘Don’t drop marijuana’

by NDASA | Apr 23, 2021 | For Employers and Workplace Safety & Wellness Professionals, Marijuana & CBD, Resources, Uncategorized

“Don’t Drop Marijuana” explains why marijuana and THC, the active ingredient of the cannabis plant, should not be dropped from drug-testing programs and panels. Please click here to review the video on Vimeo.com.  This video is produced by Drug Free Business, a...

NDASA answers frequently asked questions about marijuana and the workplace

by NDASA | Apr 23, 2021 | For Employers and Workplace Safety & Wellness Professionals, Resources

As NDASA Members, we are often asked these common questions that can cause confusion and frustration for employers when it comes to employee marijuana use, the workplace drug & alcohol policy and workplace safety. Below is a simple Q&A you may find helpful...

NDASA overview of CBD and drug testing

by NDASA | Apr 23, 2021 | For Employers and Workplace Safety & Wellness Professionals, Marijuana & CBD, Resources

This is a quick-hit handout designed to promote understanding about CBD, an ingredient of the cannabis plant. To download this guide in a .pdf file format, please click here. CBD There is currently NO over-sight by the U.S. Food & Drug Administration of the CBD...

What every employer should know about marijuana and the workplace

by NDASA | Apr 23, 2021 | For Employers and Workplace Safety & Wellness Professionals, Marijuana & CBD, Resources

Marijuana is an impairing substance. The user experiences reduced motor coordination, short-term memory loss and altered reaction time, all of which has destructive effects in the workplace. High doses of THC, the active ingredient in the cannabis plant, can cause...

Search this site

Stay in touch

  • Follow
  • Follow
  • Follow
  • Follow

Give to NDASA

Invest in safe and drug-free communities and workplaces and support NDASA.
Give now

Latest News & Updates

  • Apr 14, 2025C/TPA best-practice recomendations for ensuring client compliance
  • Apr 14, 2025Building a Defensible Breath Alcohol Testing Program
  • Apr 14, 202510 Reasons Why A Drug Testing Policy Needs to Be Updated Regularly
  • Apr 14, 2025From Invisible to Influential: How AI Can Elevate Credibility and Drive Sales in the Drug Testing Industry
  • Apr 14, 2025Leaders on the frontline: Tackling substance use with empathy and insight

Topics We Track

  • Advocacy (14)
  • Business Development (7)
  • Committee Reports (1)
  • DOT (19)
  • Drug & Alcohol Testing (54)
  • Drug Legislation (17)
  • Feature (119)
  • FMCSA (7)
  • For Drug Testing Industry Professionals (24)
  • For Employers and Workplace Safety & Wellness Professionals (18)
  • Industry News (31)
  • Marijuana & CBD (24)
  • Member Benefits (4)
  • Membership (6)
  • MROs (3)
  • NDASA Conference (18)
  • NDASA Guidance (4)
  • NDASA News (4)
  • Newsletter Only (9)
  • Opioids (3)
  • Oral Fluid Testing (2)
  • Partners (1)
  • Resources (36)
  • Substance Use (5)
  • Substance Use/Addiction (10)
  • The Voice (6)
  • Training (4)
  • Uncategorized (25)
  • Workplace Safety (17)

  • C/TPA best-practice recomendations for ensuring client compliance
  • Building a Defensible Breath Alcohol Testing Program
  • 10 Reasons Why A Drug Testing Policy Needs to Be Updated Regularly
  • From Invisible to Influential: How AI Can Elevate Credibility and Drive Sales in the Drug Testing Industry
  • Leaders on the frontline: Tackling substance use with empathy and insight

Legal Documents

  • Articles of Incorporation
  • Exemption Letter
  • IRS Designation Letter

NDASA Bylaws

  • Bylaws

Careers

Visit our job board

NDASA Policies

  • Privacy Policy
  • Security Policy
  • Refund Policy
  • Shipping Policy

Join the Newsletter

Proud Member of

Thank you to our sponsors

 

© 2023 National Drug and Alcohol Screening Association • All Rights Reserved • Web Powered by Media Salad